These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8745548)

  • 21. Clevidipine: a novel ultra-short-acting calcium antagonist.
    Prlesi L; Cheng-Lai A
    Cardiol Rev; 2009; 17(3):147-52. PubMed ID: 19384089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Antihypertensive effectiveness and tolerance of cicletanine. Results obtained with bitherapy].
    Tarrade T; Berthet P; Paillasseur JL; Bosquet D; Allard M
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():103-8. PubMed ID: 2575367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Omapatrilat.
    Armstrong PW; Lorell BH; Nissen S; Borer J
    Circulation; 2002 Aug; 106(6):e9011-2. PubMed ID: 12187916
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and safety of isradipine in hypertension.
    Shepherd AM; Carr AA; Davidov M; Hamilton J; Schnaper H; Velasquez M; Brockway B; Prisant LM; Hamilton B; Gonasun L
    J Cardiovasc Pharmacol; 1989 Apr; 13(4):580-5. PubMed ID: 2470995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo and in vitro effects of cicletanine in spontaneously hypertensive rats.
    Auguet M; Guillon JM; Delaflotte S; Le Hegarat M; Pirotzky E; Clostre F; Braquet P
    Drugs Exp Clin Res; 1988; 14(2-3):89-95. PubMed ID: 3416727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The kaliuretic impact of cicletanine compared to hydrochlorothiazide.
    Whaley-Connell A; Sowers JR
    J Hypertens; 2012 Apr; 30(4):691-2. PubMed ID: 22418907
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of cicletanine with other antihypertensive drugs in SHR-SP models.
    Malherbe E; Le Hegarat M; Clostre F; Braquet P
    Drugs Exp Clin Res; 1988; 14(2-3):83-8. PubMed ID: 2970955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dose-effectiveness relationship of cicletanine at short-term in moderately to severely hypertensive patients].
    Fritel D
    Arch Mal Coeur Vaiss; 1989 Nov; 82 Spec No 4():99-102. PubMed ID: 2514676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cicletanine for the treatment of pulmonary arterial hypertension.
    Waxman AB; Lawler L; Cornett G
    Arch Intern Med; 2008 Oct; 168(19):2164-6. PubMed ID: 18955648
    [No Abstract]   [Full Text] [Related]  

  • 30. The detection rates of inter-arm systolic blood pressure difference vary with blood pressure levels in hypertensive patients under antihypertensive therapy.
    Sun H; Li P; Su H; Wang J; Hu W; Li J; Liu Y; Cheng X
    Int J Cardiol; 2014 Apr; 172(3):e419-20. PubMed ID: 24444483
    [No Abstract]   [Full Text] [Related]  

  • 31. Antihypertensive effect of non-diuretic doses of cicletanine on a stress-induced model in the rat.
    Castro A; Florentino A; Fuentes JA
    Drugs Exp Clin Res; 1988; 14(2-3):97-101. PubMed ID: 3416728
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clevidipine in the treatment of perioperative hypertension: assessing safety events in the ECLIPSE trials.
    Aronson S
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):465-72. PubMed ID: 19419254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Evaluation of the 24-hour effect of a once-daily antihypertensive drug on the diurnal blood pressure profile].
    Abetel G; Karly M; Soret P
    Schweiz Med Wochenschr; 1990 Dec; 120(49):1890-3. PubMed ID: 2148223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antihypertensive efficacy and safety of olmesartan and ramipril in elderly patients with mild to moderate systolic and diastolic essential hypertension.
    Mallion JM; Omboni S; Barton J; Van Mieghem W; Narkiewicz K; Panzer PK; Puig JG; Stefanadis C; Zweiker R;
    Blood Press Suppl; 2011 Apr; 1():3-11. PubMed ID: 21091270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypertension in the advanced old aged: prevalence and treatment in comparative urban and rural survey].
    Wilmańska J; Bień B; Wojszel B
    Przegl Lek; 2002; 59(4-5):252-5. PubMed ID: 12183980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Value and limits of arterial pressure monitoring in the evaluation of the effectiveness of antihypertensive agents].
    Palatini P; Mos L; Guzzardi G; Martina S; Businaro R; Pessina AC
    G Clin Med; 1990 Mar; 71(3):211-9. PubMed ID: 2194881
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of hypertensive crises with calcium antagonists].
    Nicita-Mauro V; Barbera N; Savica V; Frisina N; Ceruso D
    Boll Soc Ital Cardiol; 1978; 23(9):1469-76. PubMed ID: 553621
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of antihypertensive therapy: discrepancies between office and ambulatory recorded blood pressure.
    Waeber B; Rutschmann B; Nüssberger J; Brunner HR
    J Hypertens Suppl; 1991 Dec; 9(3):S53-6. PubMed ID: 1798001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of ambulatory blood pressure monitoring as a decision-making tool in hypertensive pharmacotherapy.
    Buckman J; Garrett BB; Garrett SS
    Bibl Cardiol; 1987; (42):114-7. PubMed ID: 3632606
    [No Abstract]   [Full Text] [Related]  

  • 40. [Results of the Munich blood pressure study and the structure of Munich blood pressure program].
    Keil U; Stieber J; Döring A; Fricke H
    Offentl Gesundheitswes; 1982 Nov; 44(11):727-32. PubMed ID: 6220243
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.